DJIA 18,010.68 -115.44 -0.64%
NASDAQ 5,070.03 -27.95 -0.55%
S&P 500 2,107.39 -13.40 -0.63%
market minute promo

STEMCELLS, INC. (NASDAQ: STEM)

0.68 -0.02 (-2.44%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

STEM $0.68 -2.44%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.70
Previous Close $0.70
Daily Range $0.67 - $0.70
52-Week Range $0.54 - $2.43
Market Cap $71.5M
P/E Ratio -1.34
Dividend (Yield) $0.00 (0.0%)
Volume 1,582,936
Average Daily Volume 3,311,840
Current FY EPS -$0.41

Sector

Healthcare

Industry

Drug Makers

STEMCELLS, INC. (STEM) Description

A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders. Website: http://www.stemcellsinc.com/

News & Commentary

Cloning: A Stem Cell Revolution?

Will the creation of cloned human stem cells create a treatment revolution and a profitable investment?

StemCells (STEM) Worth Watching: Stock Rises 10.7% - Tale of the Tape

Cantor: Time To Buy StemCells

Benzinga's Top Initiations

HC Wainwright: Buy StemCells, It's Worth $1/Share

StemCells (STEM) Q1 2015 Results - Earnings Call Webcast

Dissecting StemCells Latest Capital Raise

StemCells, Inc. Completes Enrollment of First Cohort in Phase II Pathway Study for Cervical Spinal C

StemCells, Inc. Completes Enrollment of First Cohort in Phase II Pathway Study for Cervical Spinal Cord Injury

Porat To Google Just One Of The Week's Top Management Changes; Here Are 7 More

Health Care Sector Update for 03/17/2015: STEM,ESPR,CNAT

Benzinga's Top #PreMarket Losers

See More STEM News...

STEM's Top Competitors

STEM $0.68 (-2.44%)
Current stock: STEM
GILD $112.27 (-0.51%)
Current stock: GILD
CELG $114.44 (-0.43%)
Current stock: CELG
AMGN $156.26 (-0.69%)
Current stock: AMGN